Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Exchange Rate Effect (2020 - 2025)

Historic Exchange Rate Effect for Gain Therapeutics (GANX) over the last 6 years, with Q3 2025 value amounting to $6667.0.

  • Gain Therapeutics' Exchange Rate Effect fell 9825.84% to $6667.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$104320.0, marking a year-over-year decrease of 12388.97%. This contributed to the annual value of -$527168.0 for FY2024, which is 20793.69% down from last year.
  • Per Gain Therapeutics' latest filing, its Exchange Rate Effect stood at $6667.0 for Q3 2025, which was down 9825.84% from $260070.0 recorded in Q2 2025.
  • Gain Therapeutics' Exchange Rate Effect's 5-year high stood at $483249.0 during Q4 2023, with a 5-year trough of -$480592.0 in Q4 2024.
  • For the 5-year period, Gain Therapeutics' Exchange Rate Effect averaged around $21815.2, with its median value being $21723.0 (2021).
  • Per our database at Business Quant, Gain Therapeutics' Exchange Rate Effect plummeted by 125169.17% in 2024 and then soared by 188193.87% in 2025.
  • Over the past 5 years, Gain Therapeutics' Exchange Rate Effect (Quarter) stood at $64508.0 in 2021, then surged by 250.42% to $226051.0 in 2022, then surged by 113.78% to $483249.0 in 2023, then crashed by 199.45% to -$480592.0 in 2024, then skyrocketed by 101.39% to $6667.0 in 2025.
  • Its Exchange Rate Effect stands at $6667.0 for Q3 2025, versus $260070.0 for Q2 2025 and $109535.0 for Q1 2025.